Ingredient or product comparison
GHK-Cu Cycling: Application Phase vs Washout Phase Comparison
Understanding the biological and practical differences between application and washout phases clarifies why tolerance to GHK-Cu cosmetic cycling requires structured breaks rather than dose adjustments or formulation changes. Application Phase (On-Cycle) 8–12 w
This source-based comparison does not add ratings or recommend a winner.
- Understanding the biological and practical differences between application and washout phases clarifies why tolerance to GHK-Cu cosmetic cycling requires structured breaks rather than dose adjustments or formulation changes.
- Application Phase (On-Cycle)
- 8–12 weeks
- High integrin density weeks 1–8, progressive downregulation weeks 9–12
- Peak rate weeks 2–8 (150–200% baseline), declining weeks 9–12 (120–140% baseline)
- Elevated intracellular copper, rising metallothionein expression
- Hyaluronic acid, niacinamide, peptides targeting different pathways (Matrixyl, argireline)
- Progressive improvement weeks 2–10, plateau weeks 10–12
- Captures peak receptor responsiveness; extension beyond 12 weeks produces diminishing returns
- Washout Phase (Off-Cycle)
- 4–6 weeks
- Progressive receptor upregulation, returns to baseline by week 4–5
- Gradual decline to baseline (100% by week 4)
- Copper clearance, metallothionein normalization
- Vitamin C (ascorbic acid), retinoids, antioxidants (resveratrol, niacinamide)
- Maintained texture and firmness from prior cycle; no regression if matrix support continues
- Allows complete receptor recovery; shorter breaks (<4 weeks) result in incomplete sensitivity restoration
- Continuous Use (No Cycling)
- >16 weeks uninterrupted
- Persistent downregulation, integrin expression 40–60% below baseline
- Sustained suppression (100–110% baseline despite continued application)
- Chronic elevation, high metallothionein, reduced lysyl oxidase activity
- Same as application phase but with progressively lower efficacy
- Initial improvement weeks 2–10, plateau weeks 10–16, minimal further change beyond week 16
- Receptor adaptation negates benefits of continued use; produces lower cumulative collagen synthesis than cycling protocols over 12-month period
- The comparison makes the case for cycling unambiguous: continuous use produces an initial response followed by an extended plateau, while structured cycling delivers repeated response peaks that accumulate greater total collagen remodeling. Tolerance to GHK-Cu cosmetic cycling isn't an inconvenience to work around. It's the biological reality that defines optimal protocol design.